News Roundup: Biden Executive Order, Vaccines for Pregnant Women
Here’s a roundup of the latest news coverage from Drug Topics®.
Biden Pushes for Lower Drug Prices in an Executive Order
President Biden issued an executive order, with a plan unveiled today pushing the US Department of Health and Human Services to increase support for biosimilars to combat high prescription drug prices.
https://www.drugtopics.com/view/biden-pushes-for-lower-drug-prices-in-an-executive-order
Early-Stage Trials Begin for Dual COVID-19, Flu Vaccine
Novavax Incorporation announced on Monday that its combined flu and COVID-19 vaccine elicited working antibodies against the viruses in a preclinical study.
https://www.drugtopics.com/view/early-stage-trials-begin-for-dual-covid-19-flu-vaccine
Pembrolizumab Approved in China for Frontline Advanced Esophageal Cancer
The National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.
COVID-19 Vaccine Safe for Pregnant Women, Analysis Shows
The Centers for Disease Control and Prevention released new findings that reveal the safety of COVID-19 vaccination in pregnant women.
https://www.drugtopics.com/view/covid-19-vaccine-safe-for-pregnant-women-analysis-shows
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
